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Although the incidence of ovarian malignancy during pregnan-
cy is extremely low (approximately 1 per 20,000 deliveries), the
possibility of a borderline tumor or cancer must be considered
when adnexal masses are detected during a prenatal ultrasound
(Cunningham et al., 2005a). Moreover, it is generally much more
difﬁcult to diagnose and manage adnexal masses during pregnancy
than in non-pregnant women because of the restriction of radio-
logical examinations.
Carcinoid tumors are neuroendocrine tumors arising from the
embryologic primitive gut derivation and typically derive from the
intestine and the bronchopulmonary system. They represent an
unusual and complex disease spectrum with protean clinical mani-
festations. Primary ovarian carcinoid tumors are of germ cell origin
and account for 1% of all carcinoid tumors and less than 0.1% of ovar-
ian malignancies. Of the primary ovarian carcinoid tumors, the
insular type is the most commonly observed in Western countries.
This type is of midgut derivation and associated with classical or
typical carcinoid syndrome caused by serotonin and its precursors
and derivatives secreted from the tumors. In contrast, trabecular
and strumal carcinoid tumors are primarily reported in Japan.
They are of foregut or hindgut origin and are related to severe
constipation induced by the production of peptide YY (PYY), an
inhibitor of intestinal mobility (Talerman and Vang, 2011; Motoyama⁎ Corresponding author. Fax: +81 96 363 5164.
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various ﬁndings on preoperative images. Therefore, the preoperative
diagnosis of these tumors may be difﬁcult, even in non-pregnant
women.
Herein, we report a case of a primary ovarian strumal carcinoid
tumor with small mucinous components accompanied by severe
constipation and carcinoembryonic antigen (CEA) elevation during
pregnancy.
Case
A 24-year-old Japanese woman gradually began to suffer from se-
vere constipation since she had undergone an appendectomy for
acute appendicitis at the age of 12. Although she passed a bowel
movement once every 2 to 4 weeks despite using laxative agents,
she had never had a physical examination for 12 years. Her menar-
che occurred at the age of 12, and periods were regular at 30-day
intervals. The patient initially presented to a primary obstetrician be-
cause of amenorrhea and was diagnosed with pregnancy at 8 weeks of
gestation. Transvaginal sonography also revealed a hypoechoic solid
mass that is 10 cm in diameter in the cul-de-sac. The patient was
referred to a general hospital. Magnetic resonance imaging (MRI)
showed a solid mass, 10×8 cm in size, with low intensity on both T2-
and T1-weighted images with small and high intensity portions on
T1-weighted images behind the uterus (Fig. 1). Metastatic ovarian
tumors were considered in the differential diagnosis because of this
characteristic MRI ﬁnding and serum CEA elevation (14.9 ng/ml, the
cutoff values were b3.5 ng/ml). Upper gastrointestinal endoscopy for
the exclusion of gastric cancer subsequently revealed no abnormalities.
The patient was then referred to Kumamoto University Hospital be-
cause of a pelvic mass and a high serum CEA level at 10 weeks of
gestation.
A pelvic examination revealed an irregular and elastic hard mass, the
size of a newborn's head, behind the uterus. Lower intestinal tract
endoscopy showednon-speciﬁc colitis and dolichocolon. After the patient
was prompted to defecate by the administration of multiple laxative
drugs over the normal dose range, the CEA level decreased (7.9 ng/ml).
We suspected an ovarian tumor with benign or low malignant potential.
As the mass would undergo torsion or be an obstruction to delivery, the
patient underwent a laparotomy at 13 weeks of gestation.
The tumor arose from the right ovary with a small amount of
straw-colored ascites. A cytologic examination revealed no malig-
nant cells in the ascites. A right salpingo-oophorectomy was
performed. Macroscopically, the tumor was rigid with a reddish
Fig. 1.MRI ﬁndings of the tumor. (a) An axial T1-weighted image showed the high signal intensity area without fat suppression in the tumor of low signal intensity (arrow head). (b) An axial
T2-weighted image showed an area of high signal intensity thatwas consistentwith the high signal intensity area on the T1-weighted image (arrowhead). The arrows indicate the pelvicmass.
U: uterus.
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tions revealed a yellowish-white solid mass with a few cystic areas
containing mucus (Fig. 2). A pathological examination conﬁrmed the
diagnosis of a strumal carcinoid tumor with mucinous cystadenoma
(Fig. 3a, b). The neuroendocrine tumor cells showed immunoreactivity
with chromogranin A, synaptophysin, CD56 and PYY (Fig. 3c). No
immunoreactivitywas observedwith CEA. Becausemitosis and necrosis
were not observed and the Mib-1 labeling index was less than 2% by
immunohistochemistry, we decided that the patient could continue
the pregnancy under careful observation. A postoperative bowel move-
ment was observed within 48 h, and thereafter the patient had a bowel
movement every daywithout the use of laxative drugs following tumor
removal. The CEA level had fallen under the limit within 3 weeks
(1.6 ng/ml). Her prenatal course was uneventful. The patient delivered
a 2960 g female newborn by cesarean section at 38 weeks of gestation
because of cephalopelvic disproportion. Since contrast-enhanced whole-
body computed tomography (CT) scanning showed no abnormalities
2 months after delivery, she was diagnosed as stage Ia. The patient is in
good condition without any evidence of tumor recurrence 11 months
after her operation.Fig. 2. The cut section of the tumor. The cut section revealed a yellowish-white solid
mass with a few cystic areas containing mucus (arrow).Discussion
Solid tumors of the ovary must be differentially diagnosed from
malignant epithelial tumors, germ cell tumors, sex cord stromal
tumors and metastatic tumors. The preoperative diagnosis of an
ovarian solid mass, particularly during pregnancy, is more difﬁcult
because possible examinations are restricted and blood examina-
tions, including tumor markers and hormone tests, are variable dur-
ing pregnancy (Cunningham et al., 2005b). The treatment course of
a pregnant woman should also be determined deliberately by the
exclusion of a malignant tumor.
Although preoperative serum levels of CEA, CA125 or CA19-9 can
be elevated in a non-pregnant case of PYY-positive ovarian carcinoid
tumor, it is difﬁcult to interpret their elevation during pregnancy.
Among them, CEA is not inﬂuenced by pregnancy (Cheli et al.,
1999). In the present case, the patient's serum CEA level was high
at the ﬁrst visit. The level was decreased by approximately half be-
fore the tumor removal due to the reduced constipation following
the administration of laxative agents. Furthermore, CEA was not
detected in the tumor cells by immunostaining. We speculate that the
high serum CEA level may have been induced by the existence of
nonspeciﬁc colitis due to static stool for approximately 1 month
because an elevated circulating CEA level can be observed in a patient
with inﬂammatory bowel disease (Loewenstein and Zamcheck, 1978).
The elevation of serum tumor markers must be evaluated as not only
direct products from a tumor but also a reﬂector of other clinical
manifestations.
Primary ovarian carcinoids histologically present a variety of pat-
terns, including insular, trabecular, strumal and mucinous. A mixed
type has also been reported, which is composed of any combination of
the pure types. Primary ovarian carcinoids also arise in association
with mature cystic teratomas or mucinous tumors; therefore, a preop-
erative diagnosis is extremely difﬁcult (Talerman and Vang, 2011). As
such,most have been diagnosed based on postoperative pathologyﬁnd-
ings. Small parts of the solid tumor in this case showed high signal in-
tensity on both T1- and T2-weighted images without fat suppression,
which generally indicates the existence of mucus. The histopathological
ﬁndings of the tumor subsequently showed a strumal carcinoid with a
mucinous component. This ﬁnding may contribute to the preoperative
differential diagnosis from other solid tumors of the ovary.
A PYY-positive ovarian carcinoid accompanied by severe constipation
was ﬁrst reported in Japan (Motoyama et al., 1992). Although similar
cases were thereafter reported in Japan and other Asian countries, no
cases have been reported during pregnancy. PYY is the gastrointestinal
Fig. 3. Pathological and immunohistochemical ﬁndings of the tumor. (a) The solid parts of the tumor showed that thyroid follicles containing colloid merge with ribbons of
neoplastic cells in dense ﬁbrous tissue stroma. Hematoxylin–eosin staining. Original magniﬁcation 200×. (b) The cystic components in the tumor were composed of
single-layered mucinous epithelial cells. Hematoxylin–eosin staining. Original magniﬁcation 200×. (c) Carcinoid tumor cells showed positive staining for PYY. Methyl
green counter-staining. Original magniﬁcation 200×.
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response to oral nutrient ingestion. PYY physiologically inhibits
many GI functions, including gastric acid secretion, gastric emptying,
small bowel and colonic chloride secretion, mouth to cecum transit
time, pancreatic exocrine secretion and pancreatic insulin secretion.
PYY also inhibits jejunal and colonic motilities. PYY circulates in two
active forms: PYY (1–36) and PYY (3–36). PYY (1–36) increases
appetite and stimulates weight gain, and PYY (3–36), the truncated
form of PYY, has effect opposite to PYY (1–36) (Ballantyne, 2006).
The structure of PYY localized in the tumor could not be analyzed;
however, its major function was estimated to inhibit intestinal
mobility. In basic research, the chronic administration of PYY to
pregnant mice or the transgenic overexpression of PYY to pregnant
mice has been shown to induce a neural tube defect in embryos
(Yuzuriha et al., 2007). Therefore, the fetus must be carefully
observed in cases that occur during pregnancy. In the present case,
no adverse effects on her offspring have been observed until the
last follow-up. According to previous reports, the incidence of
PYY-positive ovarian carcinoid must differ between Western coun-
tries and Asian countries including Japan. The patient's race will
also be useful information for diagnosis. Almost all primary trabecu-
lar and strumal carcinoid tumors occur in women with stage I disease
and have an excellent outcome (Lee et al., 2003). Nevertheless, a case
of multiple metastases with a higher mitotic rate and focal necrosis
has been reported (Kurabayashi et al., 2010). The presence of mitoses
or necroses in the tumor will be useful for predicting a poor prognosis.
In view of her pathological ﬁndings, shewill have a good prognosis, and
she is scheduled to be followed up by physical examinations, tumormarkers, ultrasounds, and CT scans. A redevelopment of severe consti-
pationmay be a predictive symptom during a follow-up period because
a case of liver metastasis with reappearance of severe constipation of
10 months after surgery was reported (Matsuda et al., 2002).
In conclusion, it is necessary to know the clinical characteristics of
primary ovarian strumal carcinoid tumors to ensure their appropriate
diagnosis and management.
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